NOVAVAX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.89 USD | 0.00% |
|
-9.53% | -18.96% |
| Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
Presenter SpeechEric Joseph (Analysts)All right. Good morning, and welcome to the 40th Annual ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Companyâs proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Calendar
2024-05-06
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
3.89
USD
Average target price
15.4
USD
Spread / Average Target
+295.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.96% | 544M | |
| -1.82% | 41.35B | |
| +42.66% | 40.38B | |
| +2.56% | 39.05B | |
| -12.11% | 26.67B | |
| +3.09% | 24.07B | |
| -24.16% | 18.36B | |
| +22.12% | 11.6B | |
| -3.74% | 11.68B | |
| +7.75% | 11.15B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Transcript : Novavax, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 09
